129 related articles for article (PubMed ID: 17054712)
1. Investigation of the effects of sulfonylurea exposure on pancreatic beta cell metabolism.
Brennan L; Hewage C; Malthouse JP; McClenaghan NH; Flatt PR; Newsholme P
FEBS J; 2006 Nov; 273(22):5160-8. PubMed ID: 17054712
[TBL] [Abstract][Full Text] [Related]
2. Effects of metformin on BRIN-BD11 beta-cell insulin secretory desensitization induced by prolonged exposure to sulphonylureas.
Irwin N; McKinney JM; Bailey CJ; Flatt PR; McClenaghan NH
Diabetes Obes Metab; 2010 Dec; 12(12):1066-71. PubMed ID: 20977577
[TBL] [Abstract][Full Text] [Related]
3. Prolonged L-alanine exposure induces changes in metabolism, Ca(2+) handling and desensitization of insulin secretion in clonal pancreatic beta-cells.
McClenaghan NH; Scullion SM; Mion B; Hewage C; Malthouse JP; Flatt PR; Newsholme P; Brennan L
Clin Sci (Lond); 2009 Feb; 116(4):341-51. PubMed ID: 18702613
[TBL] [Abstract][Full Text] [Related]
4. [Extrapancreatic effects of sulfonylurea compounds. IV. Increase of the effect of insulin due to tolbutamide, glibornuride, and glibenclamide in vitro].
Beyer J; Gather W; Schöffling K
Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2179. PubMed ID: 4198966
[No Abstract] [Full Text] [Related]
5. Differential effect of sulfonylureas on production of reactive oxygen species and apoptosis in cultured pancreatic beta-cell line, MIN6.
Sawada F; Inoguchi T; Tsubouchi H; Sasaki S; Fujii M; Maeda Y; Morinaga H; Nomura M; Kobayashi K; Takayanagi R
Metabolism; 2008 Aug; 57(8):1038-45. PubMed ID: 18640379
[TBL] [Abstract][Full Text] [Related]
6. Insulin exocytosis in Goto-Kakizaki rat beta-cells subjected to long-term glinide or sulfonylurea treatment.
Kawai J; Ohara-Imaizumi M; Nakamichi Y; Okamura T; Akimoto Y; Matsushima S; Aoyagi K; Kawakami H; Watanabe T; Watada H; Kawamori R; Nagamatsu S
Biochem J; 2008 May; 412(1):93-101. PubMed ID: 18254725
[TBL] [Abstract][Full Text] [Related]
7. [Extrapancreatic effects of sulfonylurea compounds. 3. Studies on the additional blood sugar decreasing and antilipolytic effect of tolbutamide, glibornuride, and glibenclamide on completely pancreatectomized dogs, chronically treated with insulin during acute experiment and following pretreatment with sulfonylurea compounds using small doses of sulfonylurea].
Beyer J; Cordes U; Sell G; Schöffling K
Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2176. PubMed ID: 4198965
[No Abstract] [Full Text] [Related]
8. Glibenclamide treatment recruits beta-cell subpopulation into elevated and sustained basal insulin synthetic activity.
Ling Z; Wang Q; Stangé G; In't Veld P; Pipeleers D
Diabetes; 2006 Jan; 55(1):78-85. PubMed ID: 16380479
[TBL] [Abstract][Full Text] [Related]
9. Sulfonylureas inhibit metabolic flux through rat liver pyruvate carboxylase reaction.
White CW; Rashed HM; Patel TB
J Pharmacol Exp Ther; 1988 Sep; 246(3):971-4. PubMed ID: 3138409
[TBL] [Abstract][Full Text] [Related]
10. Specific desensitization of sulfonylurea- but not imidazoline-induced insulin release after prolonged tolbutamide exposure.
McClenaghan NH; Ball AJ; Flatt PR
Biochem Pharmacol; 2001 Mar; 61(5):527-36. PubMed ID: 11239495
[TBL] [Abstract][Full Text] [Related]
11. Sulfonylurea and glinide reduce insulin content, functional expression of K(ATP) channels, and accelerate apoptotic beta-cell death in the chronic phase.
Takahashi A; Nagashima K; Hamasaki A; Kuwamura N; Kawasaki Y; Ikeda H; Yamada Y; Inagaki N; Seino Y
Diabetes Res Clin Pract; 2007 Sep; 77(3):343-50. PubMed ID: 17316868
[TBL] [Abstract][Full Text] [Related]
12. [Extrapancreatic effects of sulfonylurea compounds. I. Studies on the effect of tolbutamide and glibornuride on blood sugar, nonesterified fatty acids, glycerin, lactate and pyruvate in the pancreatectomized dog chronically treated with insulin].
Beyer J; Cordes U; Krall H; Sell G; Schöffling K
Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2167. PubMed ID: 4679246
[No Abstract] [Full Text] [Related]
13. Changes in plasma amino acids levels and "in vivo" gluconeogenesis from alanine in rats chronically treated with sulfonylureas.
Alemany M; Palou A; Codina J; Herrera E
Diabete Metab; 1978 Sep; 4(3):181-6. PubMed ID: 101403
[No Abstract] [Full Text] [Related]
14. Effect of tolbutamide and glyburide on pyruvate kinase flux in isolated rat hepatocytes.
Judd RL; Kunjathoor VV; Pillai UA; Ferguson PW; Medon PJ
Life Sci; 1992; 50(23):PL203-8. PubMed ID: 1317934
[TBL] [Abstract][Full Text] [Related]
15. Cellular loci of sulfonylurea actions.
Lebovitz HE
Diabetes Care; 1984; 7 Suppl 1():67-71. PubMed ID: 6376031
[TBL] [Abstract][Full Text] [Related]
16. Lack of Ca2+ ionophoretic activity of hypoglycemic sulfonylureas in excitable cells and isolated secretory granules.
Gylfe E; Hellman B
Mol Pharmacol; 1982 Nov; 22(3):715-20. PubMed ID: 7155128
[TBL] [Abstract][Full Text] [Related]
17. Desensitization of sulphonylurea- and nutrient-induced insulin secretion following prolonged treatment with glibenclamide.
Ball AJ; Flatt PR; McClenaghan NH
Eur J Pharmacol; 2000 Nov; 408(3):327-33. PubMed ID: 11090651
[TBL] [Abstract][Full Text] [Related]
18. Detrimental actions of metabolic syndrome risk factor, homocysteine, on pancreatic beta-cell glucose metabolism and insulin secretion.
Patterson S; Flatt PR; Brennan L; Newsholme P; McClenaghan NH
J Endocrinol; 2006 May; 189(2):301-10. PubMed ID: 16648297
[TBL] [Abstract][Full Text] [Related]
19. Fructus Corni suppresses hepatic gluconeogenesis related gene transcription, enhances glucose responsiveness of pancreatic beta-cells, and prevents toxin induced beta-cell death.
Chen CC; Hsu CY; Chen CY; Liu HK
J Ethnopharmacol; 2008 May; 117(3):483-90. PubMed ID: 18400427
[TBL] [Abstract][Full Text] [Related]
20. [Action of the sulfonylureas tolbutamide and glypentide on the lacticdehydrogenase plasma levels (author's transl)].
García-Rafanell J; Morell-Mestre J
Rev Esp Fisiol; 1974 Jun; 30(2):91-6. PubMed ID: 4421448
[No Abstract] [Full Text] [Related]
[Next] [New Search]
